Cases 11 - 20 of 41
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2020cv13103
Plaintiff:
JANSSEN PHARMACEUTICALS, INC., JANSSEN PHARMACEUTICA NV and JANSSEN RESEARCH & DEVELOPMENT, LLC
Counter Claimant:
MYLAN LABORATORIES LIMITED
Defendant:
MYLAN PHARAMACEUTICALS, INC. and MYLAN INSTITUTIONAL LLC
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
HOLCOMB et al v. AUROBINDO PHARMA, LTD. et al
as 1:2020cv10381
Plaintiff:
PHV ALYSON OLIVER and SANDRA HOLCOMB
Defendant:
AUROBINDO PHARMA USA INC., AUROBINDO PHARM, LTD., CVS HEALTH and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
as 1:2020cv00804
Defendant:
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Mylan Laboratories Limited
as 1:2020cv00761
Plaintiff:
Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Defendant:
Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
TURREY v. AUROBINDO PHARMA LIMITED et al
as 1:2020cv06111
Defendant:
MYLAN PHAMACEUTICALS INC., PRINSTON PHARMACEUTICAL INC. d/b/a SOLCO HEALTHCARE LLC, RITE AID CORPORATION and others
Plaintiff:
JIMMY TURREY
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. et al
as 1:2020cv00445
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Limited
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Dr. Reddys Laboratories, Inc. et al
as 1:2019cv02053
Defendant:
MSN Laboratories Private Limited, Dr. Reddys Laboratories, Inc., Hetero USA Inc. and others
Plaintiff:
Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271
WITTE et al v. ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD et al
as 1:2019cv16971
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO LTD, A-S MEDICAL SOLUTIONS LLC, AUROBINDO PHARMA USA and others
Plaintiff:
PATRICIA ANN WITTE, KERRIE KATHLEEN STEGER, REPRESENTATIVE PATRICIA ANN WITTE and others
In Re:
VALSARTAN N-NITROSODIMETHYLAMINE (NDMA) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332
Janssen Pharmaceuticals, Inc. et al v. Mylan Laboratories Limited et al
as 1:2019cv01488
Plaintiff:
Janssen Pharmaceutica NV and Janssen Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals Inc., Mylan Laboratories Limited and Mylan Institutional LLC
Cause Of Action: 35 U.S.C. § 271
JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED et al
as 2:2019cv16484
Plaintiff:
JANSSEN PHARMACEUTICA NV and JANSSEN PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., MYLAN LABORATORIES LIMITED and MYLAN INSTITUTIONAL LLC
Cause Of Action: 28 U.S.C. § 1338
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
